🔴 Cresco Labs is trading 6% down as immediate reason remains unclear

Cresco Labs is trading 5.97% down at $0.63, with no clear company-specific news explaining the October 6 decline.

• Earlier Q2 results showed $173 million in revenue, up 15% sequentially, and $40 million in adjusted EBITDA, up 20% sequentially.
• The broader market is up, so its gains do not explain the stock’s drop; the immediate reason remains unclear.